Wave Life Stock Story

WVE -  USA Stock  

USD 4.28  0.29  7.27%

Lets try to digest the odds of Wave Life to fully recover from the latest dip as its shares went up 9.11%. This firm current daily volatility is 4.52 percent, with a beta of 1.29 and an alpha of -0.26 over DOW. As many millenniums are excited about current volatility, it is only fair to digest Wave Life Sci. We will evaluate why recent Wave Life price moves suggest a bounce in November.
Published over a month ago
View all stories for Wave Life | View All Stories
Should you trade Wave Life Sci after the latest volatility surge?
Wave Life runs under Healthcare sector within Biotechnology industry.
We provide recommendation to complement the prevalent expert consensus on Wave Life Sci. Our dynamic recommendation engine utilizes a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at the time.
Investing in Wave Life, just like investing in any other equity instrument, is characterized by a strong risk-return correlation. High risks mean high returns and low risk means lower expected returns. Risk management is the act of identifying and assessing the potential risk and developing strategies to minimize these risks and earn maximum possible profits while holding Wave Life along with other instruments in the same portfolio. Using conventional technical analysis and fundamental analysis to select individual securities into a portfolio complements risk management and adds value to overall investors' investing strategies.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Wave Life's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Wave Life in the context of predictive analytics.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Wave Life. Your research has to be compared to or analyzed against Wave Life's peers to derive any actionable benefits. When done correctly, Wave Life's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Wave Life Sci.

How important is Wave Life's Liquidity

Wave Life financial leverage refers to using borrowed capital as a funding source to finance Wave Life Sci ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Wave Life financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Wave Life's total debt and its cash.

How Wave Life utilizes its cash?

To perform a cash flow analysis of Wave Life, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Wave Life is receiving and how much cash it distributes out in a given period. The Wave Life cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.

Wave Life Correlation with Peers

Investors in Wave Life can reduce exposure to individual asset risk by holding a diversified portfolio of assets in addition to a long position in Wave Life Sci. Diversification will allow for the same portfolio return with reduced risk. The correlation table of Wave Life and its peers is a two-dimensional matrix that shows the correlation coefficient between pairs of securities Wave Life is related in some way. The cells in the table are color-coded to highlight significantly positive and negative relationships. Each cell shows the correlation between one pair of equities and can be used to run pair trading strategies or create efficient portfolios with your current brokerage.
Please check volatility of Wave Life for more details

Another angle On Wave Life

Wave Life Sci shows Sharpe Ratio of -0.0663, which attests that the company had -0.0663% of return per unit of risk over the last 3 months. Macroaxis standpoint towards determining the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Wave Life Sci exposes twenty-eight different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to check out Wave Life Sci market risk adjusted performance of (0.19), and Mean Deviation of 3.31 to validate the risk estimate we provide.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Another 3 percent surge for Wave Life

Latest Information Ratio is up to -0.06. Price may dip again.
As of the 17th of October 2021, Wave Life maintains the market risk adjusted performance of (0.19), and Mean Deviation of 3.31. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Wave Life Sci, as well as the relationship between them. Specifically, you can use this information to find out if the company will indeed mirror its model of past data patterns, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Wave Life Sci, which can be compared to its rivals. Please check out Wave Life Sci coefficient of variation, as well as the relationship between the treynor ratio and semi variance to decide if Wave Life Sci is priced fairly, providing market reflects its latest price of 5.15 per share. Given that Wave Life Sci has jensen alpha of (0.26), we strongly advise you to confirm Wave Life Sci's prevalent market performance to make sure the company can sustain itself at a future point.

Our Final Perspective on Wave Life

Although some companies in the biotechnology industry are either recovering or due for a correction, Wave Life may not be performing as strong as the other in terms of long-term growth potentials. The inconsistency in the assessment between current Wave Life valuation and our trade advice on Wave Life is due to the recent market swings and your selection of investing horizon. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Wave Life.

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of Wave Life Sci. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com